Home / Biotechnology / Global Synthetic Biology Market
Global Synthetic Biology Market - Market Research Report

Global Synthetic Biology Market

Published Date:Aug 2025
Industry: Biotechnology
Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Format: PDF
Page: 200
Forecast Period: 2025-2033
Historical Range: 2020-2024
Request Sample Enquiry Before Buying Speak to Analyst

Global Synthetic Biology Market Segmentation, By Tool (Oligonucleotides and Synthetic DNA {Oligonucleotides/Primers, Synthetic Genes, DNA Libraries}, Enzymes {Polymerases, Ligases, Nucleases, Restriction Enzymes}, Chassis Organisms {Microbial, Mammalian Cells, Other Host Organisms}, Software & Design Tools, {Bioinformatics Platforms, DNA Design & Sequencing Software}), By Technology (Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Site-Directed Mutagenesis, Cloning & Assembly, Microfluidics, Phage Engineering), By Application (Healthcare {Therapeutics, Drug Discovery & Development, Diagnostics}, Industrial Applications {Biofuels & Renewable Energy, Bioplastics & Bio-based Materials, Bio-Manufacturing}, Food & Agriculture, Environmental Applications), By End User (Biotechnology and Pharmaceutical Companies, Academic & Research Institutes, Food & Agricultural Companies, Energy & Chemical Companies, Contract Research & Manufacturing Organizations (CROs/CMOs))- Industry Trends and Forecast to 2033

 

Global Synthetic Biology Market size was valued at USD 18239.3 million in 2024 and is expected to grow at a CAGR of 19.4% during the forecast period of 2025 to 2033.

 

Global Synthetic Biology Market Overview

Synthetic biology is an interdisciplinary difficulty that combines biology, engineering, and computational technological know-the way to format and gather new natural systems or re-engineer gift ones for useful purposes. It lets in enhancements such as engineered microorganisms for biofuel production, lab-grown meat, biosensors, gene therapies, and sustainable bioplastics. Advances in DNA sequencing, gene editing devices like CRISPR, and computational modeling have improved its applications for the duration of healthcare, agriculture, commercial enterprise biotechnology, and environmental sustainability. While ethical concerns, biosafety issues, and regulatory annoying conditions persist, developing investments, collaborations, and technological breakthroughs are positioning synthetic biology as a transformative force of future clinical and commercial enterprise innovation.

 

Global Synthetic Biology Market Scope

Factors

Description

Years Considered

·         Historical Period: 2020-2023

·         Base Year: 2024

·         Forecast Period: 2025-2033

Segments

·         By Tool: Oligonucleotides and Synthetic DNA {Oligonucleotides/Primers, Synthetic Genes, DNA Libraries}, Enzymes {Polymerases, Ligases, Nucleases, Restriction Enzymes}, Chassis Organisms {Microbial, Mammalian Cells, Other Host Organisms}, Software & Design Tools, {Bioinformatics Platforms, DNA Design & Sequencing Software}

·         By Technology: Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Site-Directed Mutagenesis, Cloning & Assembly, Microfluidics, Phage Engineering

·         By Application: Healthcare {Therapeutics, Drug Discovery & Development, Diagnostics}, Industrial Applications {Biofuels & Renewable Energy, Bioplastics & Bio-based Materials, Bio-Manufacturing}, Food & Agriculture, Environmental Applications

·         By End User: Biotechnology and Pharmaceutical Companies, Academic & Research Institutes, Food & Agricultural Companies, Energy & Chemical Companies, Contract Research & Manufacturing Organizations (CROs/CMOs)

Countries Catered

North America

·         United States

·         Canada

·         Mexico

Europe

·         United Kingdom

·         Germany

·         France

·         Spain

·         Italy

·         Rest of Europe

Asia Pacific

·         China

·         India

·         Japan

·         Australia

·         South Korea

·         Rest of Asia Pacific

Latin America

·         Brazil

·         Argentina

·         Rest of Latin America

Middle East & Africa

·         Saudi Arabia

·         South Africa

·         Rest of MEA

Key Companies

·         Bota Biosciences Inc.

·         Codexis, Inc.

·         Creative Biogene.

·         Creative Enzymes.

·         Enbiotix, Inc.

·         Illumina, Inc.

·         Merck Kgaa

·         New England Biolabs

·         Eurofins Scientific

·         Novozymes

Market Trends

·         Expansion of biofoundries for large-scale DNA design and high-throughput experimentation.

·         Synthetic biology in food and agriculture

 

Global Synthetic Biology Market Dynamics

The dynamics of the artificial biology marketplace are driven by strong factors, emerging trends, increasing opportunities, and key challenges and constraints shaping its growth trajectory. Key drivers include rapid improvements in DNA sequencing, synthesis, and gene-editing technologies, especially CRISPR, which have decreased costs and increased efficiency, making artificial biology more accessible across industries. Rising sustainable answers, along with biofuels, bioplastics, and engineered crops, in conjunction with growing programs in healthcare for drug discovery, gene therapies, and vaccine development, are similarly propelling marketplace adoption. Trends along with the enlargement of biofoundries for high-throughput experimentation, the usage of AI and computational biology for bio-design, and improvements in lab-grown meals and microbial fertilizers, are growing new pathways for commercialization. Opportunities lie in business biotechnology, agriculture, environmental sustainability, and personalised medicine, with artificial biology imparting answers for pollutant control, carbon capture, and precision health.

 

However, excessive R&D fees, regulatory uncertainties, biosafety risks, and constrained focus in growing economies pose the most important restraints. Additionally, moral debates round synthetic life, demanding situations in scaling lab-primarily based totally studies to business production, and complicated intellectual assets landscapes avert speedy growth. Ensuring biosafety, addressing dual-use concerns, and bridging interdisciplinary talent gaps remain tremendously demanding situations. Despite those barriers, developing authorities and personal region investments, strategic partnerships, and technological breakthroughs are anticipated to power artificial biology towards transformative effects throughout healthcare, agriculture, and business sectors.

 

Global Synthetic Biology Market Segment Analysis

The artificial biology marketplace is segmented into tool, technology, application, and give up consumer, reflecting its vast and interdisciplinary growth. By tool, the marketplace is pushed through oligonucleotides and artificial DNA, along with primers, artificial genes, and DNA libraries, which function the muse for gene enhancing and molecular biology studies. Enzymes including polymerases, ligases, nucleases, and limit enzymes play a crucial function in DNA manipulation and artificial circuit creation, at the same time as chassis organisms along with microbial, mammalian cells, and different engineered hosts are primary systems for growing therapeutics, biofuels, and commercial products. Software and layout tools, along with bioinformatics systems and DNA layout & sequencing software, are an increasingly essential for optimizing bio-layout and accelerating the artificial workflow.

 

By technology, gene synthesis and genome engineering lead the segment, permitting unique genetic adjustments and creation of new pathways. Sequencing technology and bioinformatics help large-scale genomic analysis, at the same time as site-directed mutagenesis, cloning & assembly, microfluidics, and phage engineering decorate precision and scalability of studies and product improvement. In terms of application, healthcare dominates the marketplace, with artificial biology permitting novel therapeutics, superior diagnostics, and green drug discovery and improvement pipelines. Industrial programs are increasing rapidly, especially in biofuels, renewable energy, bioplastics, and bio-primarily based totally materials, providing sustainable options to petroleum-primarily based totally products. Food and agriculture constitute every other key segment, with engineered crops, microbial fertilizers, and lab-grown meat gaining momentum, at the same time as environmental programs consist of carbon capture, waste degradation, and bioremediation.

 

By end user, biotechnology and pharmaceutical businesses stay the most important adopters, leveraging artificial biology for drug pipelines and superior therapies. Academic and studies institutes play a pivotal function in innovation and essential discoveries, at the same time as meals and agricultural businesses combine artificial biology to decorate crop yield and meals sustainability. Energy and chemical businesses are exploring bio-primarily based totally manufacturing methods, and settlement studies and production organizations (CROs/CMOs) offer specialised offerings to boost up commercialization. Overall, segmentation highlights the various programs and give up-consumer base which can be riding the fast growth of artificial biology throughout healthcare, commercial, and environmental sectors.

 

Global Synthetic Biology Market Regional Analysis

The artificial biology marketplace reveals sturdy nearby variation, pushed through variations in studies infrastructure, investments, and adoption. North America dominates the marketplace, supported through superior biotechnology ecosystems, sturdy investment from authorities and private players, and the presence of main artificial biology companies, especially in the U.S. and Canada. Europe holds a enormous share, with international locations inclusive of the UK, Germany, and France actively making an investment in bio-primarily based totally industries, gene-modifying technologies, and sustainable programs in energy, food, and materials. Asia-Pacific is predicted to witness the quickest growth, fueled by growing healthcare needs, increasing biotech infrastructure, and growing authority’s projects in international locations like China, India, and Japan. The vicinity additionally advantages from developing investments in agricultural biotechnology and commercial packages. Meanwhile, Latin America and the Middle East & Africa are rising markets, in which increasing pharmaceutical and agricultural sectors, coupled with growing interest in renewable energy, offer untapped possibilities for artificial biology adoption.

 

Global Synthetic Biology Market Key Players

·         Bota Biosciences Inc.

·         Codexis, Inc.

·         Creative Biogene.

·         Creative Enzymes.

·         Enbiotix, Inc.

·         Illumina, Inc.

·         Merck Kgaa

·         New England Biolabs

·         Eurofins Scientific

·         Novozymes

 

Recent Developments

In September 2024, Telesis Bio announced a strategic collaboration with Beckman Coulter Life Sciences to establish scalable, on-premise DNA synthesis biofoundries. This combines Telesis Bio’s high-fidelity Gibson SOLA enzymatic DNA synthesis platform with Beckman's automation expertise—enabling fast, robust, and localized DNA production, a potential game-changer for synthetic biology R&D.

 

Research Methodology

At Foreclaro Global Research, our research methodology is firmly rooted in a comprehensive and systematic approach to market research. We leverage a blend of reliable public and proprietary data sources, including industry reports, government publications, company filings, trade journals, investor presentations, and credible online databases. Our analysts critically evaluate and triangulate information to ensure accuracy, consistency, and depth of insights. We follow a top-down and bottom-up data modelling framework to estimate market sizes and forecasts, supplemented by competitive benchmarking and trend analysis. Each research output is tailored to client needs, backed by transparent data validation practices, and continuously refined to reflect dynamic market conditions.

Table of Contents

Chapter 1.  Introduction

1.1.  Report Description

1.2.  Key Market Segments

1.3.  Regulatory Scenario

1.4.  Executive Summary

Chapter 2.  Research Methodology

2.1.  Secondary Research

2.2.  Primary Research

2.3.  Secondary Analyst Tools and Models

Chapter 3.  Market Dynamics

3.1.  Market driver analysis

3.1.1.  Rising demand for sustainable solutions in agriculture, energy, and industrial biotechnology

3.1.2.  Growing applications in healthcare for drug discovery, gene therapy, vaccine development, and personalized medicine

3.2.  Market restraint analysis

3.2.1.  High R&D costs and long development timelines

3.3.  Market Opportunity

3.3.1.  Healthcare innovations such as engineered cell therapies, biosensors, and synthetic vaccines

3.4.  Regulatory uncertainties around genetically modified organisms and engineered biological systems

Chapter 4.  Market Variables and Outlook

4.1.  SWOT Analysis

4.1.1.  Strengths

4.1.2.  Weaknesses

4.1.3.  Opportunities

4.1.4.  Threats

4.2.  PESTEL Analysis

4.2.1.  Political Landscape

4.2.2.   Economic Landscape

4.2.3.  Social Landscape

4.2.4.  Technological Landscape

4.2.5.  Environmental Landscape

4.2.6.  Legal Landscape

4.3.  Porter’s Five Forces Analysis

4.3.1.  Bargaining Power of Suppliers

4.3.2.  Bargaining Power of Buyers

4.3.3.  Threat of Substitute

4.3.4.  Threat of New Entrant

4.3.5.  Competitive Rivalry

4.4.  Value Chain Analysis

4.5.  Covid Impact Analysis

Chapter 5.  Synthetic Biology Market: Tool Estimates & Trend Analysis

5.1.  Synthetic Biology Market value share and forecast, (2020 to 2033)

5.2.  Incremental Growth Analysis and Infographic Presentation

5.3.  Oligonucleotides and Synthetic DNA

5.3.1.  Oligonucleotides/Primers

5.3.2.  Synthetic Genes

5.3.3.  DNA Libraries

5.4.  Enzymes

5.4.1.  Polymerases

5.4.2.  Ligases

5.4.3.  Nucleases

5.4.4.  Restriction Enzymes

5.5.  Chassis Organisms

5.5.1.  Microbial

5.5.2.  Mammalian Cells

5.5.3.  Other Host Organisms

5.6.  Software & Design Tools

5.6.1.  Bioinformatics Platforms

5.6.2.  DNA Design & Sequencing Software

Chapter 6.  Synthetic Biology Market: Technology Estimates & Trend Analysis

6.1.  Synthetic Biology Market value share and forecast, (2020 to 2033)

6.2.  Incremental Growth Analysis and Infographic Presentation

6.3.  Gene Synthesis

6.4.  Genome Engineering

6.5.  Sequencing

6.6.  Bioinformatics

6.7.  Site-Directed Mutagenesis

6.8.  Cloning & Assembly

6.9.  Microfluidics

6.10. Phage Engineering

Chapter 7.  Synthetic Biology Market: Application Estimates & Trend Analysis

7.1.  Synthetic Biology Market value share and forecast, (2020 to 2033)

7.2.  Incremental Growth Analysis and Infographic Presentation

7.3.  Healthcare

7.3.1.  Therapeutics

7.3.2.  Drug Discovery & Development

7.3.3.  Diagnostics

7.4.  Industrial Applications

7.4.1.  Biofuels & Renewable Energy

7.4.2.  Bioplastics & Bio-based Materials

7.4.3.  Bio-Manufacturing

7.5.  Food & Agriculture

7.6.  Environmental Applications

Chapter 8.  Synthetic Biology Market: End User Estimates & Trend Analysis

8.1.  Synthetic Biology Market value share and forecast, (2020 to 2033)

8.2.  Incremental Growth Analysis and Infographic Presentation

8.3.  Biotechnology and Pharmaceutical Companies

8.4.  Academic & Research Institutes

8.5.  Food & Agricultural Companies

8.6.  Energy & Chemical Companies

8.7.  Contract Research & Manufacturing Organizations (CROs/CMOs)

Chapter 9.  Synthetic Biology Market: Regional Estimates & Trend Analysis

9.1.  Synthetic Biology Market value share and forecast, (2020 to 2033)

9.2.  Incremental Growth Analysis and Infographic Presentation

9.3.  North America

9.4.  Europe

9.5.  Asia Pacific

9.6.  Middle East & Africa

9.7.  Latin America

Chapter 10.      Synthetic Biology Market: Country Estimates & Trend Analysis

10.1. Synthetic Biology Market value share and forecast, (2020 to 2033)

10.2. Incremental Growth Analysis and Infographic Presentation

10.3. United States

10.4. Canada

10.5. Mexico

10.6. United Kingdom

10.7. France

10.8. Germany

10.9. Italy

10.10. Spain

10.11. China

10.12. India

10.13. Japan

10.14. South Korea

10.15. Australia

10.16. Brazil

10.17. Argentina

10.18. Saudi Arabia

10.19. South Africa

Chapter 11.      Competitive Landscape

11.1. Company Market Share Analysis

11.2. Vendor Landscape

11.3. Competition Dashboard

Chapter 12.      Company Profiles

12.1. Bota Biosciences Inc.

12.1.1. Company Overview

12.1.2. Financial Details

12.1.3. Product Analysis

12.1.4. Recent Developments

12.2. Codexis, Inc.

12.2.1. Company Overview

12.2.2. Financial Details

12.2.3. Product Analysis

12.2.4. Recent Developments

12.3. Creative Biogene.

12.3.1. Company Overview

12.3.2. Financial Details

12.3.3. Product Analysis

12.3.4. Recent Developments

12.4. Creative Enzymes.

12.4.1. Company Overview

12.4.2. Financial Details

12.4.3. Product Analysis

12.4.4. Recent Developments

12.5.  Integra LifeSciences

12.5.1. Company Overview

12.5.2. Financial Details

12.5.3. Product Analysis

12.5.4. Recent Developments

12.6. Enbiotix, Inc.

12.6.1. Company Overview

12.6.2. Financial Details

12.6.3. Product Analysis

12.6.4. Recent Developments

12.7. Illumina, Inc.

12.7.1. Company Overview

12.7.2. Financial Details

12.7.3. Product Analysis

12.7.4. Recent Developments

12.8. Merck Kgaa

12.8.1. Company Overview

12.8.2. Financial Details

12.8.3. Product Analysis

12.8.4. Recent Developments

12.9. New England Biolabs

12.9.1. Company Overview

12.9.2. Financial Details

12.9.3. Product Analysis

12.9.4. Recent Development

12.10. Eurofins Scientific

12.10.1.            Company Overview

12.10.2.            Financial Details

12.10.3.            Product Analysis

12.10.4.            Recent Developments

12.11. Novozymes

12.11.1.            Company Overview

12.11.2.            Financial Details

12.11.3.            Product Analysis

12.11.4.            Recent Developments

Segmentation

Synthetic Biology Market, Tool Outlook (Revenue - USD Million, 2020 - 2033)

Oligonucleotides and Synthetic DNA

·         Oligonucleotides/Primers

·         Synthetic Genes

·         DNA Libraries

Enzymes

·         Polymerases

·         Ligases

·         Nucleases

·         Restriction Enzymes

Chassis Organisms

·         Microbial

·         Mammalian Cells

·         Other Host Organisms

Software & Design Tools

·         Bioinformatics Platforms

·         DNA Design & Sequencing Software

 

Synthetic Biology Market, Technology Outlook (Revenue - USD Million, 2020 - 2033)

Gene Synthesis

Genome Engineering

Sequencing

Bioinformatics

Site-Directed Mutagenesis

Cloning & Assembly

Microfluidics

Phage Engineering

 

Synthetic Biology Market, Application Outlook (Revenue - USD Million, 2020 - 2033)

Healthcare

·         Therapeutics

·         Drug Discovery & Development

·         Diagnostics

Industrial Applications

·         Biofuels & Renewable Energy

·         Bioplastics & Bio-based Materials

·         Bio-Manufacturing

Food & Agriculture

Environmental Applications

 

Synthetic Biology Market, End User Outlook (Revenue - USD Million, 2020 - 2033)

Biotechnology and Pharmaceutical Companies

Academic & Research Institutes

Food & Agricultural Companies

Energy & Chemical Companies

Contract Research & Manufacturing Organizations (CROs/CMOs)

 

Synthetic Biology Market, Regional Outlook (Revenue - USD Million, 2020 - 2033)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Methodology

Review our research methodology and quality standards for details about source selection, validation, forecasting, and review.

At Foreclaro Global Research, our research methodology is built to deliver clear, data-backed intelligence that supports confident decision-making. By combining rigorous secondary research, primary validations, and advanced forecasting models, we produce insights that are not only reliable but also strategically relevant for our clients.

 

1. Defining the Research Framework

Every study begins with a clear understanding of our client’s goals. We establish the market scope, define critical variables, and build a research framework tailored to the specific project. This upfront clarity ensures that our findings are sharply aligned with the strategic questions being addressed.

 

2. Robust Data Collection

Our analysts extract high-integrity data from a broad mix of credible sources including government databases, annual reports, regulatory filings, trade publications, scientific journals, and trusted industry portals. This secondary research is then supported with targeted primary inputs through interviews with key industry stakeholders—such as executives, subject matter experts, and channel partners—to capture real-world insights and contextual depth.

 

3. Advanced Forecasting and Modeling

To estimate market size and growth, we employ a hybrid of top-down and bottom-up modeling techniques. Our analysts apply proven forecasting models using historical data trends, economic indicators, technology adoption rates, and demand patterns. Sensitivity analysis and scenario modeling (base, optimistic, conservative) are incorporated to account for market volatility and uncertainty.

 

4. Data Triangulation and Validation

Accuracy is non-negotiable. We cross-validate every data point by triangulating it across three dimensions: source credibility, numerical consistency, and contextual alignment. This ensures our insights are not just statistically correct but strategically dependable. Discrepancies are resolved using subject expertise and multi-perspective reviews to deliver a balanced, unbiased analysis.

 

5. Quality Assurance and Final Review

Before delivery, each report undergoes a stringent quality assurance process. Our research output is reviewed for structure, clarity, consistency, and compliance with global standards. The final deliverable is tailored for decision-makers, whether it's a comprehensive industry report, data dashboard, or strategic presentation.

 

Why Our Methodology Works

What sets us apart is our adaptive data architecture and our commitment to analytical clarity. Every study is built with flexibility to accommodate dynamic markets, while our team blends quantitative rigor with domain-specific expertise. This allows us to deliver research that goes beyond information, we deliver intelligence that leads to action.

Choose License Type

Get a Sample Report

The sample report includes key data points such as market estimates, growth rates, market size, regional insights, and market segmentation

Request Sample Report
Read the Press Release for this report

Related Reports